Ticagrelor: a safe and effective approach for overcoming clopidogrel resistance in patients with stent thrombosis?

被引：11

作者：

Samos, Matej ^{[1
]}

Fedor, Marian ^{[2
]}

Kovar, Frantisek ^{[1
]}

Duraj, Lukas ^{[2
]}

Stanciakova, Lucia ^{[2
]}

Galajda, Peter ^{[1
]}

Stasko, Jan ^{[2
]}

Kubisz, Peter ^{[2
]}

Mokan, Marian ^{[1
]}

机构：

[1] Comenius Univ, Jessenius Fac Med Martin, Dept Internal Med 1, Kollarova 2, Martin 03659, Slovakia

[2] Comenius Univ, Jessenius Fac Med Martin, Dept Hematol & Blood Transfus, Natl Ctr Hemostasis & Thrombosis, Martin 03659, Slovakia

来源：

BLOOD COAGULATION & FIBRINOLYSIS | 2016年 / 27卷 / 02期

关键词：

high on-treatment platelet reactivity; percutaneous coronary intervention; stent thrombosis; ticagrelor; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; PRASUGREL; PRETREATMENT; EFFICACY; IMPACT;

D O I：

10.1097/MBC.0000000000000406

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Stent thrombosis is a morbid complication following percutaneous coronary intervention (PCI). Dual antiplatelet therapy significantly reduces stent thrombosis risk. However, the antiplatelet response to clopidogrel - the most frequently used ADP receptor antagonist in post-PCI patients - varies among individuals. High on-treatment platelet reactivity was repeatedly associated with the risk of stent thrombosis. Ticagrelor is a novel ADP receptor blocker that has shown greater, more rapid and more consistent platelet inhibition than clopidogrel. This agent offers a unique mechanism of action, no relevant pharmacological interactions, consistent platelet inhibition, and a good safety profile. This article reviews the prospective use of ticagrelor in the treatment of stent thrombosis in acute coronary syndrome patients undergoing PCI of culprit coronary lesion. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.

引用

页码：117 / 120

页数：4

共 29 条

[1] Platelet Reactivity Measurements Reveal Patient Noncompliance During Ticagrelor Maintenance Therapy [J].

Alexopoulos, Dimitrios ;

Xanthopoulou, Ioanna ;

Stavrou, Katerina ;

Hahalis, George ;

Davlouros, Periklis .

CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (12)

[2] Ticagrelor in Clopidogrel-Resistant Patients Undergoing Maintenance Hemodialysis [J].

Alexopoulos, Dimitrios ;

Xanthopoulou, Ioanna ;

Plakomyti, Theodora-Eleni ;

Goudas, Pavlos ;

Koutroulia, Eleni ;

Goumenos, Dimitrios .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 60 (02) :332-333

[3] Impact of P2Y12 Inhibitory Effects Induced by Clopidogrel on Platelet Procoagulant Activity in Type 2 Diabetes Mellitus Patients [J].

Angiolillo, Dominick J. ;

Capranzano, Piera ;

Desai, Bhaloo ;

Shoemaker, Steven B. ;

Charlton, Ronald ;

Zenni, Martin M. ;

Guzman, Luis A. ;

Bass, Theodore A. .

THROMBOSIS RESEARCH, 2009, 124 (03) :318-322

[4] High On-Treatment Platelet Reactivity After Prasugrel Loading Dose and Cardiovascular Events After Percutaneous Coronary Intervention in Acute Coronary Syndromes [J].

Bonello, Laurent ;

Pansieri, Michel ;

Mancini, Julien ;

Bonello, Roland ;

Maillard, Luc ;

Barnay, Pierre ;

Rossi, Philippe ;

Ait-Mokhtar, Omar ;

Jouve, Bernard ;

Collet, Frederic ;

Peyre, Jean Pascal ;

Wittenberg, Olivier ;

de Labriolle, Axel ;

Camilleri, Elise ;

Cheneau, Edouard ;

Cabassome, Elma ;

Dignat-George, Francoise ;

Camoin-Jau, Laurence ;

Paganelli, Franck .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (05) :467-473

[5] Prasugrel Monitoring and Bleeding in Real World Patients [J].

Cayla, Guillaume ;

Cuisset, Thomas ;

Silvain, Johanne ;

O'Connor, Stephen A. ;

Kerneis, Mathieu ;

Castelli, Christel ;

Quilici, Jacques ;

Bonnet, Jean-Louis ;

Alessi, Marie-Christine ;

Morange, Pierre-Emmanuel ;

Collet, Jean-Philippe ;

Montalescot, Gilles .

AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (01) :38-44

[6] Stent Thrombosis A Clinical Perspective [J].

Dangas, George D. .

JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (10) :1082-1092

[7] Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting [J].

Collet, Jean-Philippe ;

Cuisset, Thomas ;

Range, Gregoire ;

Cayla, Guillaume ;

Elhadad, Simon ;

Pouillot, Christophe ;

Henry, Patrick ;

Motreff, Pascal ;

Carrie, Didier ;

Boueri, Ziad ;

Belle, Loic ;

Van Belle, Eric ;

Rousseau, Helene ;

Aubry, Pierre ;

Monsegu, Jacques ;

Sabouret, Pierre ;

O'Connor, Stephen A. ;

Abtan, Jeremie ;

Kerneis, Mathieu ;

Saint-Etienne, Christophe ;

Barthelemy, Olivier ;

Beygui, Farzin ;

Silvain, Johanne ;

Vicaut, Eric ;

Montalescot, Gilles .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (22) :2100-2109

[8] Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety [J].

Dobesh, Paul P. ;

Oestreich, Julie H. .

PHARMACOTHERAPY, 2014, 34 (10) :1077-1090

[9] Patients With Poor Responsiveness to Thienopyridine Treatment or With Diabetes Have Lower Levels of Circulating Active Metabolite, but Their Platelets Respond Normally to Active Metabolite Added Ex Vivo [J].

Erlinge, David ;

Varenhorst, Christoph ;

Braun, Oscar O. ;

James, Stefan ;

Winters, Kenneth J. ;

Jakubowski, Joseph A. ;

Brandt, John T. ;

Sugidachi, Atsuhiro ;

Siegbahn, Agneta ;

Wallentin, Lars .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (24) :1968-1977

[10] Monitoring the Efficacy of ADP Inhibitor Treatment in Patients With Acute STEMI Post-PCI by VASP-P Flow Cytometry Assay [J].

Fedor, Marian ;

Samos, M. ;

Simonova, R. ;

Fedorova, J. ;

Skornova, I. ;

Duraj, L. ;

Stasko, J. ;

Kovar, F. ;

Mokan, M. ;

Kubisz, P. .

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2015, 21 (04) :334-338

← 1 2 3 →